1887

Abstract

We characterized antibiotic resistance and virulence of uropathogenic (UPEC) strains isolated from urinary tract infections (UTIs) in patients hospitalized in urology departments. A prospective multicentre study was initiated from March 2009 and lasted until February 2010 in French urology units. All patients with asymptomatic bacteriuria (ABU), acute cystitis, acute pyelonephritis or acute prostatitis in whom UPEC was detected were included. Antimicrobial resistance and virulence factors were compared among the different groups. To identify independent associations between virulence markers and the risk of UTI, we used a multivariate logistic regression. We included 210 patients (mean age: 65.8 years; 106 female). Episode of UTI was community acquired in 72.4 %. ABU was diagnosed in 67 cases (31.9 %), cystitis in 52 cases (24.7 %), pyelonephritis in 35 cases (16.7 %) and prostatitis in 56 cases (26.7 %). ABU was more frequent in patients with a urinary catheter (76.1 vs 23.9 %, <0.001). The resistance rate was 7.6 and 24.8 % for cefotaxime and ciprofloxacin, respectively. UPEC isolated from infections belonged more frequently to phylotypes B2 and D ( =0.07). The allele II and ,, and genes were significantly more frequent in infecting strains (<0.05). In multivariate analysis, strains susceptible to ciprofloxacin were significantly associated with allele II (=0.007), (<0.001) and (<0.001) compared with the ciprofloxacin-resistant strains. To the best of our knowledge, this is the first study evaluating the antibiotic resistance and virulence features of UPEC isolated from patients hospitalized in urology departments. High resistance rates were observed, notably for ciprofloxacin, highlighting the importance of a reinforced surveillance in this setting.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000247
2016-06-01
2019-09-17
Loading full text...

Full text loading...

/deliver/fulltext/jmm/65/6/530.html?itemId=/content/journal/jmm/10.1099/jmm.0.000247&mimeType=html&fmt=ahah

References

  1. Afzal-Shah M. , Woodford N. , Livermore D. M. . ( 2001;). Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii . . Antimicrob Agents Chemother 45:, 583–588. [CrossRef] [PubMed]
    [Google Scholar]
  2. Anjum M. F. , Mafura M. , Slickers P. , Ballmer K. , Kuhnert P. , Woodward M. J. , Ehricht R. . ( 2007;). Pathotyping Escherichia coli by using miniaturized DNA microarrays. . Appl Environ Microbiol 73:, 5692–5697. [CrossRef] [PubMed]
    [Google Scholar]
  3. Barguigua A. , El Otmani F. , Talmi M. , Zerouali K. , Timinouni M. . ( 2013;). Prevalence and types of extended spectrum β-lactamases among urinary Escherichia coli isolates in Moroccan community. . Microb Pathog 61-62:, 16–22. [CrossRef]
    [Google Scholar]
  4. Batchelor M. , Hopkins K. L. , Liebana E. , Slickers P. , Ehricht R. , Mafura M. , Aarestrup F. , Mevius D. , Clifton-Hadley F. A. , other authors . ( 2008;). Development of a miniaturised microarray-based assay for the rapid identification of antimicrobial resistance genes in Gram-negative bacteria. . Int J Antimicrob Agents 31:, 440–451. [CrossRef] [PubMed]
    [Google Scholar]
  5. Blanco M. , Alonso M. P. , Nicolas-Chanoine M. H. , Dahbi G. , Mora A. , Blanco J. E. , López C. , Cortés P. , Llagostera M. , Blanco J. . ( 2009;). Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. . J Antimicrob Chemother 63:, 1135–1141. [CrossRef] [PubMed]
    [Google Scholar]
  6. Bonacorsi S. , Bidet P. , Mahjoub F. , Mariani-Kurkdjian P. , Ait-Ifrane S. , Courroux C. , Bingen E. . ( 2009;). Semi-automated rep-PCR for rapid differentiation of major clonal groups of Escherichia coli meningitis strains. . Int J Med Microbiol 299:, 402–409. [CrossRef] [PubMed]
    [Google Scholar]
  7. Branger C. , Zamfir O. , Geoffroy S. , Laurans G. , Arlet G. , Thien H. V. , Gouriou S. , Picard B. , Denamur E. . ( 2005;). Genetic background of Escherichia coli and extended-spectrum beta-lactamase type. . Emerg Infect Dis 11:, 54–61. [CrossRef] [PubMed]
    [Google Scholar]
  8. Cantón R. , Coque T. M. . ( 2006;). The CTX-M β-lactamase pandemic. . Curr Opin Microbiol 9:, 466–475. [CrossRef]
    [Google Scholar]
  9. Charlson M. E. , Charlson R. E. , Peterson J. C. , Marinopoulos S. S. , Briggs W. M. , Hollenberg J. P. . ( 2008;). The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. . J Clin Epidemiol 61:, 1234–1240. [CrossRef] [PubMed]
    [Google Scholar]
  10. Clermont O. , Johnson J. R. , Menard M. , Denamur E. . ( 2007;). Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. . Diagn Microbiol Infect Dis 57:, 129–136. [CrossRef] [PubMed]
    [Google Scholar]
  11. Clermont O. , Christenson J. K. , Denamur E. , Gordon D. M. . ( 2013;). The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. . Environ Microbiol Rep 5:, 58–65. [CrossRef] [PubMed]
    [Google Scholar]
  12. Coque T. M. , Novais A. , Carattoli A. , Poirel L. , Pitout J. , Peixe L. , Baquero F. , Cantón R. , Nordmann P. . ( 2008;). Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. . Emerg Infect Dis 14:, 195–200. [CrossRef] [PubMed]
    [Google Scholar]
  13. Drews S. J. , Poutanen S. M. , Mazzulli T. , McGeer A. J. , Sarabia A. , Pong-Porter S. , Rzayev Y. , Willey B. , Green K. , Low D. E. . ( 2005;). Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. . J Clin Microbiol 43:, 4218–4220. [CrossRef] [PubMed]
    [Google Scholar]
  14. Foxman B. . ( 2003;). Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. . Dis Mon 49:, 53–70. [CrossRef] [PubMed]
    [Google Scholar]
  15. Horcajada J. P. , Soto S. , Gajewski A. , Smithson A. , Jiménez de Anta M. T. , Mensa J. , Vila J. , Johnson J. R. . ( 2005;). Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. . J Clin Microbiol 43:, 2962–2964. [CrossRef] [PubMed]
    [Google Scholar]
  16. Jarlier V. , Nicolas M. H. , Fournier G. , Philippon A. . ( 1988;). Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. . Rev Infect Dis 10:, 867–878.[PubMed] [CrossRef]
    [Google Scholar]
  17. Johnson J. R. , Kuskowski M. A. , O'Bryan T. T. , Maslow J. N. . ( 2002;). Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diverse-source bacteremia. . J Infect Dis 185:, 1439–1447. [CrossRef] [PubMed]
    [Google Scholar]
  18. Johnson J. R. , Owens K. , Gajewski A. , Kuskowski M. A. . ( 2005;). Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. . J Clin Microbiol 43:, 6064–6072. [CrossRef] [PubMed]
    [Google Scholar]
  19. Kim J. , Lim Y. M. , Jeong Y. S. , Seol S. Y. . ( 2005;). Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum beta-lactamases in Enterobacteriaceae clinical isolates in Korea. . Antimicrob Agents Chemother 49:, 1572–1575. [CrossRef] [PubMed]
    [Google Scholar]
  20. Lavigne J. P. , Blanc-Potard A. B. , Bourg G. , Moreau J. , Chanal C. , Bouziges N. , O'Callaghan D. , Sotto A. . ( 2006;). Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M beta-lactamases. . Clin Microbiol Infect 12:, 1199–1206. [CrossRef] [PubMed]
    [Google Scholar]
  21. Lavigne J. P. , Marchandin H. , Delmas J. , Moreau J. , Bouziges N. , Lecaillon E. , Cavalie L. , Jean-Pierre H. , Bonnet R. , Sotto A. . ( 2007;). CTX-M beta-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors. . J Clin Microbiol 45:, 620–626. [CrossRef] [PubMed]
    [Google Scholar]
  22. MacCabe W. R. , Jackson G. G. . ( 1962;). Gram-negative bacteremia. . Arch Intern Med 110:, 847–852. [CrossRef]
    [Google Scholar]
  23. Mammeri H. , Van De Loo M. , Poirel L. , Martinez-Martinez L. , Nordmann P. . ( 2005;). Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. . Antimicrob Agents Chemother 49:, 71–76. [CrossRef] [PubMed]
    [Google Scholar]
  24. Medina-Polo J. , Arrébola-Pajares A. , Pérez-Cadavid S. , Benítez-Sala R. , Sopeña-Sutil R. , Lara-Isla A. , Alsonso-Isa M. , Gil-Moradillo J. , Justo-Quintas J. , Tejido-Sánchez Á. . ( 2015;). Extended-spectrum beta-lactamase-producing bacteria in a urology ward: epidemiology, risk factors and antimicrobial susceptibility patterns. . Urol Int 95:, 288–292. [CrossRef] [PubMed]
    [Google Scholar]
  25. Merle V. , Germain J. M. , Bugel H. , Nouvellon M. , Lemeland J. F. , Czernichow P. , Grise P. . ( 2002;). Nosocomial urinary tract infections in urologic patients: assessment of a prospective surveillance program including 10,000 patients. . Eur Urol 41:, 483–489.[PubMed] [CrossRef]
    [Google Scholar]
  26. Nicolas-Chanoine M. H. , Blanco J. , Leflon-Guibout V. , Demarty R. , Alonso M. P. , Caniça M. M. , Park Y. J. , Lavigne J. P. , Pitout J , Johnson J. R. . ( 2008;). Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. . J Antimicrob Chemother 61:, 273–281. [CrossRef] [PubMed]
    [Google Scholar]
  27. Pitout J. D. , Hossain A. , Hanson N. D. . ( 2004;). Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp. . J Clin Microbiol 42:, 5715–5721. [CrossRef] [PubMed]
    [Google Scholar]
  28. Potron A. , Poirel L. , Rondinaud E. , Nordmann P. . ( 2013;). Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. . Eurosurveillance 18:, 20549. [CrossRef]
    [Google Scholar]
  29. Qin X. , Hu F. , Wu S. , Ye X. , Zhu D. , Zhang Y. , Wang M. . ( 2013;). Comparison of adhesin genes and antimicrobial susceptibilities between uropathogenic and intestinal commensal Escherichia coli strains. . PLoS One 8:, e61169. [CrossRef] [PubMed]
    [Google Scholar]
  30. Vila J. , Simon K. , Ruiz J. , Horcajada J. P. , Velasco M. , Barranco M. , Moreno A. , Mensa J. . ( 2002;). Are quinolone-resistant uropathogenic Escherichia coli less virulent?. J Infect Dis 186:, 1039–1042. [CrossRef] [PubMed]
    [Google Scholar]
  31. Wada K. , Kariyama R. , Mitsuhata R. , Uehara S. , Watanabe T. , Monden K. , Kumon H. . ( 2009;). Experimental and clinical studies on fluoroquinolone-insusceptible Escherichia coli isolated from patients with urinary tract infections from 1994 to 2007. . Acta Med Okayama 63:, 263–272.[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000247
Loading
/content/journal/jmm/10.1099/jmm.0.000247
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error